Skip to main content
FDA Shortage Check

Is Precedex (Dexmedetomidine Hydrochloride Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Precedex: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Delay in shipping of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Fresenius Kabi USA, LLC, Oct 15, 2026
DRUG
Precedex
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Apr 10, 2020
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 56 presentations: 10 unavailable · 1 limited · 45 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Dexmedetomidine Hydrochloride Injection. 60 presentations from 17 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Accord Healthcare Inc.2 presentations · 2 unavailable

Contact (FDA's listing): 866-941-7875, option 2

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)

    Discontinuation of the manufacture of the drug

    NDC 16729-239-93Reverified

    Unavailable

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93)

    Discontinuation of the manufacture of the drug

    NDC 16729-432-93Reverified

    Unavailable

Fresenius Kabi USA, LLC4 presentations · 4 unavailable

Contact (FDA's listing): 888-386-1300

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)

    Estimated recovery: TBD

    NDC 63323-421-02Reverified

    Unavailable

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00)

    Expected recovery: TBD

    NDC 63323-671-00Reverified

    Unavailable

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20)

    Expected recovery: TBD

    NDC 63323-671-20Reverified

    Unavailable

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50)

    Estimated recovery: TBD

    NDC 63323-671-50Reverified

    Unavailable

Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)1 presentation · 1 unavailable

Contact (FDA's listing): See Related Information section below for customer service information

  • 200 mcg/2 mL

    Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)

    Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229

    NDC 83634-600-02Revised

    Unavailable

Par Health, USA LLC3 presentations · 3 unavailable

Contact (FDA's listing): 800-828-9393

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25)

    Please check wholesalers for inventory

    NDC 42023-146-25Reverified

    Unavailable

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20)

    Estimated recovery: TBD; Please check wholesalers for inventory

    NDC 42023-186-20Reverified

    Unavailable

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10)

    Estimated recovery: TBD; Please check wholesalers for inventory

    NDC 42023-187-10Reverified

    Unavailable

Pfizer Inc.14 presentations · 1 limited · 13 available or not stated

Contact (FDA's listing): 844-646-4398

  • 80 mcg/20 mL (4 mcg/mL)

    Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10)

    Limited Supply Available. Next Delivery and Estimated Recovery: December 2026

    NDC 0409-3301-10Revised

    Limited Availability

  • 1000 mcg/250 mL

    Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12)

    NDC 0409-7875-12Reverified

    Available

  • 1000 mcg/250 mL Glass Bottle NovaPlus

    Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01)

    NDC 0409-2815-01Reverified

    Available

  • 1000 mcg/250 mL Single Dose Glass Bottle

    Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01)

    NDC 0409-1434-01Reverified

    Available

  • 200 mcg/2 mL (100 mcg/mL)

    Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02)

    NDC 0409-1638-02Reverified

    Available

  • 200 mcg/50 mL (4 mcg/mL)

    Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20)

    NDC 0409-1454-20Reverified

    Available

  • 200 mcg/50 mL (4 mcg/mL)

    Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50)

    NDC 0409-1660-50Reverified

    Available

  • 200 mcg/50 mL (4 mcg/mL)

    Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20)

    NDC 0409-4596-20Reverified

    Available

  • 200 mcg/50 mL

    Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24)

    NDC 0409-7838-24Reverified

    Available

  • 400 mcg/100 mL (4 mcg/mL)

    Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02)

    NDC 0409-0155-02Reverified

    Available

  • 400 mcg/100 mL (4 mcg/mL)

    Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10)

    NDC 0409-1174-10Reverified

    Available

  • 400 mcg/100 mL (4 mcg/mL)

    Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10)

    NDC 0409-1596-10Reverified

    Available

  • 400 mcg/100 mL

    Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24)

    NDC 0409-7853-24Reverified

    Available

  • 80 mcg/20 mL (4 mcg/mL)

    Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20)

    NDC 0409-1660-20Reverified

    Available

Amneal Pharmaceuticals4 presentations · 4 available or not stated

Contact (FDA's listing): 866-525-7270

  • 4 mcg/mL, 100 mL

    Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1)

    NDC 70121-1389-1Reverified

    Available

  • 4 mcg/mL, 50 mL

    Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1)

    NDC 70121-1388-1Reverified

    Available

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8)

    NDC 70121-1388-8Reverified

    Available

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7)

    NDC 70121-1389-7Reverified

    Available

Azurity Pharmaceuticals, Inc4 presentations · 4 available or not stated

Contact (FDA's listing): 877-495-6856

  • 200 mcg/50 mL (4 ug/1 mL)

    Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10)

    Distributed by Wilshire Pharmaceuticals, Inc.

    NDC 52536-125-10Reverified

    Available

  • 200 mcg/50 mL (4 ug/1 mL)

    Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10)

    Distributed by Civica

    NDC 72572-127-10Reverified

    Available

  • 400 mcg/100 mL (4 ug/1 mL)

    Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08)

    Distributed by Wilshire Pharmaceuticals, Inc.

    NDC 52536-126-08Reverified

    Available

  • 400 mcg/100 mL (4 ug/1 mL)

    Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08)

    Distributed by Civica

    NDC 72572-128-08Reverified

    Available

Baxter Healthcare4 presentations · 4 available or not stated

Contact (FDA's listing): 888-229-0001

  • 200 ug/50 mL

    Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24)

    NDC 0338-9555-24Reverified

    Available

  • 200 ug/50 mL

    Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24)

    NDC 43066-555-24Reverified

    Available

  • 400 ug/100 mL

    Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12)

    NDC 0338-9557-12Reverified

    Available

  • 400 ug/100 mL

    Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)

    NDC 43066-557-12Reverified

    Available

Eugia US LLC3 presentations · 3 available or not stated

Contact (FDA's listing): 888-238-7880

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02)

    Check wholesalers for inventory

    NDC 55150-209-02Reverified

    Available

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10)

    Check wholesalers for inventory

    NDC 55150-296-10Reverified

    Available

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10)

    Check wholesalers for inventory

    NDC 55150-297-10Reverified

    Available

Gland Pharma Limited3 presentations · 3 available or not stated

Contact (FDA's listing): 855-273-0154

  • 200 ug/2 mL

    Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42)

    Marketed by Piramal Critical Care Inc.: 800-414-1901

    NDC 66794-230-42Reverified

    Available

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58)

    Distributed by DRL

    NDC 43598-975-58Reverified

    Available

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58)

    Distributed by DRL

    NDC 43598-976-58Reverified

    Available

Hikma Pharmaceuticals USA, Inc.1 presentation · 1 available or not stated

Contact (FDA's listing): 800-631-2174

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)

    Additional product will be made available as it is released.

    NDC 0143-9532-25Revised

    Available

HQ Specialty Pharma4 presentations · 4 available or not stated

Contact (FDA's listing): WG Critical Care 888-493-0861

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04)

    Marketed by WG Critical Care

    NDC 44567-600-04Reverified

    Available

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04)

    Marketed by WG Critical Care

    NDC 44567-601-04Reverified

    Available

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24)

    Marketed by WG Critical Care

    NDC 44567-602-24Reverified

    Available

  • 4 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24)

    Marketed by WG Critical Care

    NDC 44567-603-24Reverified

    Available

Jiangsu Hengrui Pharmaceuticals Co., Ltd.3 presentations · 3 available or not stated

Contact (FDA's listing): See Related Information section below for customer service information

  • 200 mcg/50 mL

    Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95)

    Marketed by Sandoz Inc.; Customer service: 800-525-8747

    NDC 0781-3494-95Reverified

    Available

  • 400 mcg/100 mL

    Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95)

    Marketed by Sandoz Inc.; Customer service: 800-525-8747

    NDC 0781-3495-95Reverified

    Available

  • 80 mcg/20 mL

    Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95)

    Marketed by Sandoz Inc.; Customer service: 800-525-8747

    NDC 0781-3493-95Reverified

    Available

Meitheal Pharmaceuticals, Inc.1 presentation · 1 available or not stated

Contact (FDA's listing): 844-824-8426

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)

    NDC 71288-505-03Reverified

    Available

Mylan Institutional, a Viatris Company3 presentations · 3 available or not stated

Contact (FDA's listing): 800-796-9526

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)

    NDC 67457-251-02Reverified

    Available

  • 200 ug/50 mL

    Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)

    NDC 67457-924-50Reverified

    Available

  • 400 ug/100 mL

    Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10)

    NDC 67457-925-10Reverified

    Available

Somerset Therapeutics, LLC2 presentations · 2 available or not stated

Contact (FDA's listing): 732-554-1037

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04)

    NDC 70069-758-04Reverified

    Available

  • 100 ug/1 mL

    Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)

    NDC 70069-759-04Reverified

    Available

What the manufacturers told FDA

  • Fresenius Kabi USA, LLC · ‘Estimated recovery: TBD’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Expected recovery: TBD’ · updated Oct 2026
  • Par Health, USA LLC · ‘Estimated recovery: TBD; Please check wholesalers for inventory’ · updated Oct 2026
  • Pfizer Inc. · ‘Limited Supply Available. Next Delivery and Estimated Recovery: December 2026’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Delay in shipping of the drug
  • Demand increase for the drug
  • Discontinuation of the manufacture of the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Other products with the same ingredient and form

A discontinuation “does not necessarily create a shortage” (FDA).

  • Accord Healthcare Inc. told FDA it will discontinue Dexmedetomidine Hydrochloride (posted ).

    “Discontinuation of the manufacture of the drug”

    FDA listing: Dexmedetomidine Hydrochloride Injection

  • Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) told FDA it will discontinue Dexmedetomidine Hydrochloride (posted ).

    “Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229”

    FDA listing: Dexmedetomidine Hydrochloride Injection

  • Slayback Pharma told FDA it will discontinue Dexmedetomidine Hydrochloride (posted ).

    “Discontinuation of the manufacture of the drug”

    FDA listing: Dexmedetomidine Hydrochloride Injection

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Precedex in shortage?
Yes. As of Oct 24, 2026, FDA lists Dexmedetomidine Hydrochloride Injection as currently in shortage: 56 presentations, 10 unavailable and 1 limited.
When will the Precedex shortage end?
FDA gives no end date. 5 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Precedex?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.